But the current ethos of the industry is a much more welcoming place
At its core, these lawsuits allege that Novo Nordisk knew, or reasonably should have known, that semaglutide carries a significant risk of causing severe gastrointestinal conditions, including gastroparesis, ileus, and intestinal obstruction , and that the company failed to adequately warn patients and healthcare providers about these risks on the drug's official label
What happens to your records and medication supply if the provider pauses operations or shuts down
If you have any doubts or questions about the medication, consult your healthcare provider for guidance
Proposal for a ValueBased Agreement to Reimburse Antiobesity Medicines in Traditional Medicare, E Trish, 2025 Frequently Asked Questions What are the potential side effects of using Ozempic and Wegovy
Spironolactone Alone vs